Rheumatology
News
Benzbromarone tops febuxostat for gout?
Benzbromarone is not approved in the United States because of concerns of acute liver injury but is approved in several other countries.
News
FDA approves combination pegloticase and methotrexate for refractory gout
In the phase 4 trial, co-administration of pegloticase and methotrexate reduced the formation of new anti-PEG antibodies.
News
Zoster vaccination does not appear to increase flare risk in patients with immune-mediated inflammatory disease
For the study, investigators used medical claims from IBM MarketScan in patients aged 50-64 years, and data from the Centers for Medicare and...
News
Large study reaffirms rare risk of TNF inhibitor–induced psoriasis in patients with RA, IBD
Compared with conventional treatment, the risk of developing nonpustular psoriasis was twofold higher among patients receiving TNFi treatment.
News
Hydroxychloroquine risk found in some older patients with RA
Hydroxychloroquine initiation in older patients with rheumatoid arthritis and a history of heart failure was associated with an increased risk of...
News
Alcohol consumption habits can predict gout tophi
Drinking frequently, drinking for at least 10 years, and drinking spirits were significantly associated with tophi development, a study finds.
Conference Coverage
Osteoporosis risk rises with air pollution levels
Chronic exposure to particulate matter 2.5 mcm or larger in size at concentrations above 25 mcg per cubic meter raised the likelihood of...
Conference Coverage
Bimekizumab calms psoriatic arthritis in phase 3 ‘BE’ trials
The dual interleukin-17 inhibitor was effective both in patients for whom TNF inhibitors failed and those who had never received a biologic...
Conference Coverage
Immunosuppressed rheumatic patients not at high risk of breakthrough COVID-19
Patients with immunomodulated inflammatory diseases are not an at-risk group for breakthrough COVID-19 infections, apart from those on anti-CD20...
Conference Coverage
Methotrexate enhances pegloticase response in uncontrolled gout
Greater efficacy and fewer infusion reactions seen with methotrexate-pegloticase combination than pegloticase alone in the placebo-controlled...